Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential.

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Placental Stem Cells

Background:

• The chorion of human term placenta is a potential source of stem cells.
• Mesenchymal stem cells (MSCs) have therapeutic potential but their source and characteristics vary.
• Identifying novel, abundant sources of multipotent stem cells is crucial for regenerative medicine.

Purpose of the Study:

• To characterize human chorionic mesenchymal stem cell (hCMSC) lines derived from the chorion of human term placenta.
• To evaluate the multipotency and therapeutic potential of hCMSCs.
• To investigate the capacity of hCMSCs to repair injured lung epithelium.

Main Methods:

• Isolation and propagation of hCMSCs from human term placenta chorion.
• Assessment of cell proliferation, telomere length, and telomerase activity.
• Characterization of hCMSCs using embryonic stem cell markers (OCT-4, NANOG, SSEA-3, TRA-1-60).
• In vitro differentiation into derivatives of all three germ layers (ectoderm, mesoderm, endoderm).
• Evaluation of hCMSC efficacy in repairing ex vivo-perfused human lung and in vitro lung epithelial cultures.

Main Results:

• hCMSC lines were established with high proliferative capacity (>100 doublings) without telomere shortening or telomerase activity.
• Cells expressed key embryonic stem cell markers, indicating pluripotency.
• hCMSCs differentiated into neuron-like cells, adipocytes, osteoblasts, endothelial-like cells, and hepatocytes.
• hCMSCs demonstrated significant repair of injured lung epithelium in both ex vivo and in vitro models.

Conclusions:

• The chorion of human term placenta is an abundant source of multipotent stem cells (hCMSCs).
• hCMSCs possess high therapeutic potential due to their differentiation capacity and regenerative properties.
• hCMSCs are promising candidates for developing novel cell-based therapies for human organ pathologies, particularly lung injury.